These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25112836)

  • 1. Toll-like receptors in the pathogenesis of human B cell malignancies.
    Isaza-Correa JM; Liang Z; van den Berg A; Diepstra A; Visser L
    J Hematol Oncol; 2014 Aug; 7():57. PubMed ID: 25112836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors: lessons to learn from normal and malignant human B cells.
    Chiron D; Bekeredjian-Ding I; Pellat-Deceunynck C; Bataille R; Jego G
    Blood; 2008 Sep; 112(6):2205-13. PubMed ID: 18591383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors in lymphoid malignancies: double-edged sword.
    Harsini S; Beigy M; Akhavan-Sabbagh M; Rezaei N
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):262-83. PubMed ID: 24051205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
    Li TT; Ogino S; Qian ZR
    World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and function of toll-like receptors in B lymphocytes].
    Liu HZ; Yang HZ; Hu ZW
    Sheng Li Ke Xue Jin Zhan; 2008 Apr; 39(2):114-8. PubMed ID: 18664173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors and their role in hematologic malignancies.
    Wolska A; Lech-Maranda E; Robak T
    Curr Mol Med; 2009 Apr; 9(3):324-35. PubMed ID: 19355914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies.
    Ntoufa S; Vilia MG; Stamatopoulos K; Ghia P; Muzio M
    Semin Cancer Biol; 2016 Aug; 39():15-25. PubMed ID: 27402288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of toll-like receptors in chronic B-cell malignancies.
    Muzio M; Bertilaccio MT; Simonetti G; Frenquelli M; Caligaris-Cappio F
    Leuk Lymphoma; 2009 Oct; 50(10):1573-80. PubMed ID: 19672768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of toll-like receptor mediated signalling in the pathogenesis of multiple myeloma.
    Abdi J; Engels F; Garssen J; Redegeld F
    Crit Rev Oncol Hematol; 2011 Nov; 80(2):225-40. PubMed ID: 21236697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of toll-like receptors on B lymphocytes.
    Dasari P; Nicholson IC; Hodge G; Dandie GW; Zola H
    Cell Immunol; 2005; 236(1-2):140-5. PubMed ID: 16188245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
    Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors: expression and involvement in multiple myeloma.
    Chiron D; Jego G; Pellat-Deuceunynck C
    Leuk Res; 2010 Dec; 34(12):1545-50. PubMed ID: 20594595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Toll-Like Receptors for Cancer Therapy.
    Braunstein MJ; Kucharczyk J; Adams S
    Target Oncol; 2018 Oct; 13(5):583-598. PubMed ID: 30229471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.
    Arvaniti E; Ntoufa S; Papakonstantinou N; Touloumenidou T; Laoutaris N; Anagnostopoulos A; Lamnissou K; Caligaris-Cappio F; Stamatopoulos K; Ghia P; Muzio M; Belessi C
    Haematologica; 2011 Nov; 96(11):1644-52. PubMed ID: 21750087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.
    Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
    Clin Exp Immunol; 2010 Jan; 159(1):11-22. PubMed ID: 19843090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation.
    Rozková D; Novotná L; Pytlík R; Hochová I; Kozák T; Bartůnková J; Spísek R
    Int J Cancer; 2010 Mar; 126(5):1132-43. PubMed ID: 19685493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors: The role in bladder cancer development, progression and immunotherapy.
    Ohadian Moghadam S; Nowroozi MR
    Scand J Immunol; 2019 Dec; 90(6):e12818. PubMed ID: 31448424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Bruton's tyrosine kinase in B cells and malignancies.
    Pal Singh S; Dammeijer F; Hendriks RW
    Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR signaling by tumor and immune cells: a double-edged sword.
    Huang B; Zhao J; Unkeless JC; Feng ZH; Xiong H
    Oncogene; 2008 Jan; 27(2):218-24. PubMed ID: 18176603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors expressed in tumor cells: targets for therapy.
    Yu L; Chen S
    Cancer Immunol Immunother; 2008 Sep; 57(9):1271-8. PubMed ID: 18256828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.